Page last updated: 2024-11-12
3-acrylamidophenylboronic acid
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
ID Source | ID |
---|---|
PubMed CID | 10321331 |
SCHEMBL ID | 235432 |
MeSH ID | M0378474 |
Synonyms (33)
Synonym |
---|
99349-68-5 |
3-acrylamidophenylboronic acid |
(3-acrylamidophenyl)boronic acid |
A846009 |
(m-acrylamidophenyl)boronic acid |
AKOS006291555 |
3-(acrylamido)phenylboronic acid |
FT-0685348 |
SCHEMBL235432 |
[3-(prop-2-enoylamino)phenyl]boronic acid |
AM808126 |
boronic acid, b-[3-[(1-oxo-2-propen-1-yl)amino]phenyl]- |
3-acrylamido-phenylboronic acid |
ULVXDHIJOKEBMW-UHFFFAOYSA-N |
(3-acrylamidophenyl)-boronic acid |
J-502078 |
AC-30997 |
DTXSID50438076 |
3-(acrylamido)phenylboronic acid, 98% |
(m-acrylamido)phenylboronic acid |
mfcd09025755 |
CS-W001006 |
GS-5726 |
[3-(prop-2-enamido)phenyl]boronic acid |
3-(acryloylamino)benzeneboronic acid |
SY066256 |
3-acrylamidophenylboronic acid (contains varying amounts of anhydride) |
3-acrylamidobenzeneboronic acid |
(m-acrylamidophenyl)boronicacid |
149698-08-8 |
phenylboronate acrylamide |
CS-0067138 |
(3-acrylamidophenyl)boronicacid |
Research Excerpts
Bioavailability
Excerpt | Reference | Relevance |
---|---|---|
" Mucoadhesive drug delivery systems have the potential to improve topical drug delivery by increasing pharmaceutical bioavailability on the anterior eye surface." | ( Phenylboronic-Acid-Based Polymeric Micelles for Mucoadhesive Anterior Segment Ocular Drug Delivery. Kedzior, S; Muirhead, B; Prosperi-Porta, G; Sheardown, H, 2016) | 0.43 |
Dosage Studied
Excerpt | Relevance | Reference |
---|---|---|
" This novel preparation can enable new combinations of plant extracts and biomaterials to adiministered through NPs or other dosage forms in order to regulate and treat diseases." | ( Nanoparticles prepared from pterostilbene reduce blood glucose and improve diabetes complications. Bian, L; Ma, Q; Shi, A; Wu, J; Yan, X; Zhang, P; Zhao, X, 2021) | 0.62 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (29)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (17.24) | 29.6817 |
2010's | 21 (72.41) | 24.3611 |
2020's | 3 (10.34) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 19.24
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (19.24) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 29 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |